Aicaigou LogoB2B WikiIndustrial Encyclopedia

Dabigatran

Updated: 2026-07-15

Overview

Dabigatran is a novel oral anticoagulant that directly inhibits thrombin (factor IIa), offering advantages over traditional vitamin K antagonists like warfarin. Developed by Boehringer Ingelheim and marketed as Pradaxa, it was first approved by the FDA in 2010 for stroke prevention in non-valvular atrial fibrillation. As a prodrug (dabigatran etexilate), it is converted to active dabigatran after oral administration. Unlike warfarin, it has predictable pharmacokinetics, doesn't require routine INR monitoring, and has fewer food and drug interactions, making it a preferred choice for many patients.

Physical and Chemical Properties

达比加群酯中间体N-4化工原料 429659-01-8 有机合成中间体江苏博思特化工科技有限公司

Dabigatran etexilate mesylate is a white to off-white crystalline powder with poor aqueous solubility but good permeability, classified as BCS class II. The compound is hygroscopic and requires careful moisture control during manufacturing and storage. The active form, dabigatran, has a molecular weight of 471.50 g/mol and binds reversibly to thrombin's active site. Its plasma protein binding is relatively low (35%), contributing to its consistent anticoagulant effect. The drug shows pH-dependent solubility, being more soluble in acidic environments which aids its absorption in the stomach.

商家经验真实案例 · 安全可信
唑嘧磺草胺残留期解析
本文探讨唑嘧磺草胺除草剂在土壤中的降解周期,分析影响残留时间的关键因素,并给出合理使用建议,帮助农户科学安排轮作计划。

Main Applications

The primary clinical use of dabigatran is for stroke prevention in patients with non-valvular atrial fibrillation, where it has demonstrated superior efficacy to warfarin with similar bleeding risks in major trials. It's also approved for treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). In orthopedic settings, dabigatran serves as an alternative to low molecular weight heparins for venous thromboembolism prophylaxis after hip or knee replacement surgery. Off-label uses include bridging therapy in some perioperative settings, though this requires careful hematologist supervision due to bleeding risks.

Safety and Storage

N-(4-氰基苯基)甘氨酸 达比加群酯中间体 42288-26-6盼得(上海)国际贸易有限公司

Dabigatran carries a boxed warning for spinal/epidural hematoma risk during neuraxial anesthesia and for premature discontinuation increasing stroke risk. Major bleeding events, while comparable to warfarin, require specific reversal strategies (idarucizumab). Storage of bulk material requires controlled room temperature (15-30°C) in tightly closed containers with desiccants. Finished products are typically packaged in moisture-resistant blister packs to maintain stability. Shelf life is generally 24-36 months when stored properly, with particular attention to humidity control in tropical climates.

商家经验真实案例 · 安全可信
铝合金汞进出口
本文探讨铝合金汞的进出口流程、注意事项及潜在应用领域,帮助相关从业者了解这一特殊材料的国际贸易要点。

B2B Procurement Guide

Pharmaceutical buyers should verify API suppliers' compliance with current Good Manufacturing Practices (cGMP) and request detailed certificates of analysis including impurity profiles. For generic procurement, bioequivalence documentation is essential. Bulk purchases should consider lead times (typically 8-12 weeks for API) and may benefit from long-term contracts given price fluctuations. Quality audits are recommended for new suppliers, with particular attention to particle size distribution controls which affect bioavailability. For formulation development, excipient compatibility studies are crucial due to dabigatran's moisture sensitivity.

Related Manufacturers